Clinical Innovation
from Monaco

Rooted in Monaco since 2001, R&D Pharma brings together research, development and manufacturing with a focus on innovation in dermatology

Products

Explore our current and pipeline products

Progress begins with recognizing a medical need — and having the expertise and determination to address it. At R&D Pharma, we bring entrepreneurial drive and pharmaceutical discipline together to advance innovation in dermatology and age related conditions. From early development to clinical evaluation and commercialization, we combine scientific ambition with the practical expertise needed to bring products to market.

Our multiple regulatory profile

R&D Pharma operates across multiple regulatory frameworks:

Pharmaceutical Activity
  • Marketing Authorization Holder (MAH)
  • Exploitant in accordance with applicable national regulations
  • Responsible for batch certification and release
  • Pharmaceutical manufacturing outsourced to qualified GMP-compliant partners
Medical Device Activity
  • ISO 13485 Quality Management System compliant
  • Manufacturer and Distributor within the European market
  • Sponsor of clinical investigations for investigational devices

Our Portfolio and Pipeline

Our Current Portfolio

Dermatological devices for professional use, supported by quality oversight and ongoing product monitoring.

  • MDC-75 — a CE-marked Class IIa medical device for professional use.

Our Development Pipeline

We advance investigational dermatological technologies through research, scientific collaboration and clinical evaluation.

  • MDC-60 – MD IIa In Technical Review
  • MDC-80 – MD IIa Pilot Trial
  • MDC-30 – a medical device under clinical investigation.

* All pipeline devices are investigational and not commercially available. Information is subject to change without notice.